MRPS28
gene geneOn this page
Also known as MRP-S28HSPC007MRPS35
Summary
MRPS28 (mitochondrial ribosomal protein S28, HGNC:14513) is a protein-coding gene on chromosome 8q21.13, encoding Small ribosomal subunit protein bS1m (Q9Y2Q9). It is a selective cancer dependency (DepMap: 30.2% of cell lines).
Mammalian mitochondrial ribosomal proteins are encoded by nuclear genes and help in protein synthesis within the mitochondrion. Mitochondrial ribosomes (mitoribosomes) consist of a small 28S subunit and a large 39S subunit. They have an estimated 75% protein to rRNA composition compared to prokaryotic ribosomes, where this ratio is reversed. Another difference between mammalian mitoribosomes and prokaryotic ribosomes is that the latter contain a 5S rRNA. Among different species, the proteins comprising the mitoribosome differ greatly in sequence, and sometimes in biochemical properties, which prevents easy recognition by sequence homology. This gene encodes a 28S subunit protein that has been called mitochondrial ribosomal protein S35 in the literature.
Source: NCBI Gene 28957 — RefSeq curated summary.
At a glance
- Gene–disease (curated): mitochondrial disease (Limited, ClinGen) — +1 more curated relationship
- GWAS associations: 5
- Clinical variants (ClinVar): 90 total — 1 pathogenic
- Phenotypes (HPO): 25
- Druggable target: yes
- Cancer dependency (DepMap): dependent in 30.2% of screened cell lines
- MANE Select transcript:
NM_014018
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:14513 |
| Approved symbol | MRPS28 |
| Name | mitochondrial ribosomal protein S28 |
| Location | 8q21.13 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MRP-S28, HSPC007, MRPS35 |
| Ensembl gene | ENSG00000147586 |
| Ensembl biotype | protein_coding |
| OMIM | 611990 |
| Entrez | 28957 |
Gene structure
Transcript identifiers
Ensembl transcripts: 17 — 16 protein_coding, 1 protein_coding_CDS_not_defined
ENST00000276585, ENST00000518271, ENST00000518371, ENST00000519120, ENST00000519386, ENST00000520946, ENST00000521434, ENST00000521605, ENST00000522987, ENST00000854562, ENST00000854563, ENST00000854564, ENST00000854565, ENST00000854566, ENST00000854567, ENST00000854568, ENST00000854569
RefSeq mRNA: 1 — MANE Select: NM_014018
NM_014018
CCDS: CCDS6226
Canonical transcript exons
ENST00000276585 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001173728 | 80030036 | 80030259 |
| ENSE00002129955 | 79918717 | 79919148 |
| ENSE00003562403 | 80002999 | 80003180 |
Expression profiles
Bgee: expression breadth ubiquitous, 140 present calls, max score 98.15.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 24.5527 / max 421.0361, expressed in 1806 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 93678 | 21.3144 | 1798 |
| 93677 | 2.9560 | 1419 |
| 93676 | 0.2822 | 110 |
Top tissues by expression
140 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| adrenal tissue | UBERON:0018303 | 98.15 | gold quality |
| right adrenal gland | UBERON:0001233 | 97.34 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 97.23 | gold quality |
| left adrenal gland | UBERON:0001234 | 96.96 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 96.87 | gold quality |
| adrenal gland | UBERON:0002369 | 96.75 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 96.67 | gold quality |
| gastrocnemius | UBERON:0001388 | 96.62 | gold quality |
| muscle of leg | UBERON:0001383 | 96.59 | gold quality |
| skeletal muscle organ | UBERON:0014892 | 96.57 | gold quality |
| islet of Langerhans | UBERON:0000006 | 96.49 | gold quality |
| heart left ventricle | UBERON:0002084 | 96.36 | gold quality |
| substantia nigra | UBERON:0002038 | 96.24 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 95.98 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 95.88 | gold quality |
| heart | UBERON:0000948 | 95.81 | gold quality |
| right atrium auricular region | UBERON:0006631 | 95.81 | gold quality |
| hypothalamus | UBERON:0001898 | 95.57 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 95.42 | gold quality |
| caudate nucleus | UBERON:0001873 | 95.36 | gold quality |
| putamen | UBERON:0001874 | 95.36 | gold quality |
| nucleus accumbens | UBERON:0001882 | 95.35 | gold quality |
| amygdala | UBERON:0001876 | 95.23 | gold quality |
| muscle tissue | UBERON:0002385 | 95.23 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 95.07 | gold quality |
| temporal lobe | UBERON:0001871 | 95.02 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 94.98 | gold quality |
| placenta | UBERON:0001987 | 94.96 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 94.95 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 94.95 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 11.40 |
| E-CURD-112 | yes | 9.78 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
4 targeting MRPS28, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-545-3P | 99.95 | 70.74 | 2783 |
| HSA-MIR-4729 | 99.69 | 72.18 | 4233 |
| HSA-MIR-208A-5P | 99.42 | 70.83 | 1913 |
| HSA-MIR-208B-5P | 99.42 | 70.83 | 1952 |
Functional genomics
DepMap (CRISPR cell-line fitness): dependent in 30.2% of screened cell lines.
Literature-anchored findings (GeneRIF, showing 1)
- MRPS28 joins the ranks of genes encoding mitoribosomal proteins linked to impaired mitoribosomal biogenesis and function in mitochondrial disease. (PMID:30566640)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | mrps28 | ENSDARG00000041538 |
| mus_musculus | Mrps28 | ENSMUSG00000040269 |
| rattus_norvegicus | Mrps28 | ENSRNOG00000032630 |
| drosophila_melanogaster | mRpS28 | FBGN0034361 |
| caenorhabditis_elegans | WBGENE00012830 |
Protein
Protein identifiers
Small ribosomal subunit protein bS1m — Q9Y2Q9 (reviewed: Q9Y2Q9)
Alternative names: 28S ribosomal protein S28, mitochondrial, 28S ribosomal protein S35, mitochondrial
All UniProt accessions (11): Q9Y2Q9, A0A0S2Z563, A0A0S2Z5D2, A0A0S2Z5H0, E5RFH3, E5RFT8, E5RGC7, E5RK86, H0YAT2, H7C5V3, U3KQQ8
UniProt curated annotations — full annotation on UniProt →
Subunit / interactions. Component of the mitochondrial small ribosomal subunit (mt-SSU). Mature mammalian 55S mitochondrial ribosomes consist of a small (28S) and a large (39S) subunit. The 28S small subunit contains a 12S ribosomal RNA (12S mt-rRNA) and 30 different proteins. The 39S large subunit contains a 16S rRNA (16S mt-rRNA), a copy of mitochondrial valine transfer RNA (mt-tRNA(Val)), which plays an integral structural role, and 52 different proteins.
Subcellular location. Mitochondrion.
Disease relevance. Combined oxidative phosphorylation deficiency 47 (COXPD47) [MIM:618958] An autosomal recessive, multisystemic, mitochondrial disorder characterized by intrauterine growth retardation, swallowing difficulties with failure to thrive, hypoglycemia, dehydration, and hepatomegaly. Additional features include global developmental delay with impaired intellectual development and absent speech, microcephaly, facial dysmorphism, cataract, sensorineural deafness, skeletal features, and cryptorchidism. Laboratory studies show metabolic acidosis, increased serum lactate, and variably impaired activity of mitochondrial respiratory complexes I, III, IV, and V in different tissues. The disease is caused by variants affecting the gene represented in this entry.
Similarity. Belongs to the bacterial ribosomal protein bS1 family.
RefSeq proteins (1): NP_054737* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR019375 | Ribosomal_bS1m | Family |
Pfam: PF10246
UniProt features (16 total): strand 7, helix 3, modified residue 2, sequence variant 2, transit peptide 1, chain 1
Structure
Experimental structures (PDB)
77 structures, top 30 by resolution.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 7QI4 | ELECTRON MICROSCOPY | 2.21 |
| 8CSS | ELECTRON MICROSCOPY | 2.36 |
| 7P2E | ELECTRON MICROSCOPY | 2.4 |
| 8RRI | ELECTRON MICROSCOPY | 2.4 |
| 9OLF | ELECTRON MICROSCOPY | 2.46 |
| 9OJM | ELECTRON MICROSCOPY | 2.5 |
| 8CSQ | ELECTRON MICROSCOPY | 2.54 |
| 8CSR | ELECTRON MICROSCOPY | 2.54 |
| 6ZM6 | ELECTRON MICROSCOPY | 2.59 |
| 7QI5 | ELECTRON MICROSCOPY | 2.63 |
| 8CSP | ELECTRON MICROSCOPY | 2.66 |
| 7PNX | ELECTRON MICROSCOPY | 2.76 |
| 8ANY | ELECTRON MICROSCOPY | 2.85 |
| 8CST | ELECTRON MICROSCOPY | 2.85 |
| 6ZM5 | ELECTRON MICROSCOPY | 2.89 |
| 7PO0 | ELECTRON MICROSCOPY | 2.9 |
| 8K2A | ELECTRON MICROSCOPY | 2.9 |
| 9PGL | ELECTRON MICROSCOPY | 2.9 |
| 7PO1 | ELECTRON MICROSCOPY | 2.92 |
| 7PO3 | ELECTRON MICROSCOPY | 2.92 |
| 9PGF | ELECTRON MICROSCOPY | 2.93 |
| 6VMI | ELECTRON MICROSCOPY | 2.96 |
| 6RW4 | ELECTRON MICROSCOPY | 2.97 |
| 6VLZ | ELECTRON MICROSCOPY | 2.97 |
| 7QI6 | ELECTRON MICROSCOPY | 2.98 |
| 8QRN | ELECTRON MICROSCOPY | 2.98 |
| 9PSM | ELECTRON MICROSCOPY | 2.98 |
| 8OIS | ELECTRON MICROSCOPY | 3 |
| 9G5C | ELECTRON MICROSCOPY | 3 |
| 9G5D | ELECTRON MICROSCOPY | 3 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9Y2Q9-F1 | 77.94 | 0.53 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (2): 73, 133
Function
Pathways and Gene Ontology
Reactome pathways
7 pathways
| ID | Pathway |
|---|---|
| R-HSA-5368286 | Mitochondrial translation initiation |
| R-HSA-5389840 | Mitochondrial translation elongation |
| R-HSA-5419276 | Mitochondrial translation termination |
| R-HSA-9937383 | Mitochondrial ribosome-associated quality control |
| R-HSA-392499 | Metabolism of proteins |
| R-HSA-5368287 | Mitochondrial translation |
| R-HSA-72766 | Translation |
MSigDB gene sets: 304 (showing top):
GSE18804_BRAIN_VS_COLON_TUMORAL_MACROPHAGE_DN, TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP, STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN, GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN, GOBP_MITOCHONDRIAL_TRANSLATION, TGACCTY_ERR1_Q2, GOBP_TRANSLATION, chr12p11, WEI_MYCN_TARGETS_WITH_E_BOX, ONKEN_UVEAL_MELANOMA_UP, WANG_LMO4_TARGETS_DN, GOMF_STRUCTURAL_CONSTITUENT_OF_RIBOSOME, GOCC_MITOCHONDRIAL_ENVELOPE, HNF4_01, NIKOLSKY_BREAST_CANCER_8Q12_Q22_AMPLICON
GO Biological Process (1): mitochondrial translation (GO:0032543)
GO Molecular Function (1): RNA binding (GO:0003723)
GO Cellular Component (5): mitochondrion (GO:0005739), mitochondrial inner membrane (GO:0005743), mitochondrial small ribosomal subunit (GO:0005763), ribosome (GO:0005840), ribonucleoprotein complex (GO:1990904)
Reactome top-level categories
Rollup of top-3 pathways:
| Category | Pathways |
|---|---|
| Mitochondrial translation | 4 |
| Translation | 1 |
| Metabolism of proteins | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| mitochondrion | 1 |
| translation | 1 |
| mitochondrial gene expression | 1 |
| nucleic acid binding | 1 |
| cytoplasm | 1 |
| intracellular membrane-bounded organelle | 1 |
| organelle inner membrane | 1 |
| mitochondrial membrane | 1 |
| organellar small ribosomal subunit | 1 |
| mitochondrial ribosome | 1 |
| mitochondrial protein-containing complex | 1 |
| intracellular membraneless organelle | 1 |
| protein-containing complex | 1 |
Protein interactions and networks
STRING
1240 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| MRPS28 | GSTCD | Q8NEC7 | 614 |
| MRPS28 | DEXI | O95424 | 571 |
| MRPS28 | MRPS18A | Q9NVS2 | 550 |
| MRPS28 | MRPS18B | Q9Y676 | 464 |
| MRPS28 | SMYD1 | Q8NB12 | 460 |
| MRPS28 | CENPU | Q71F23 | 447 |
| MRPS28 | AURKAIP1 | Q9NWT8 | 446 |
| MRPS28 | MOGAT2 | Q3SYC2 | 441 |
| MRPS28 | DRD3 | P35462 | 407 |
| MRPS28 | TSR3 | Q9UJK0 | 347 |
| MRPS28 | SLC26A4 | O43511 | 346 |
| MRPS28 | MRPL17 | Q9NRX2 | 346 |
| MRPS28 | UQCR10 | Q9UDW1 | 339 |
| MRPS28 | MRPS26 | Q9BYN8 | 310 |
| MRPS28 | CIITA | P33076 | 298 |
IntAct
115 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| YBX1 | HNRNPR | psi-mi:“MI:0914”(association) | 0.770 |
| KBTBD7 | METTL15 | psi-mi:“MI:0914”(association) | 0.730 |
| ERBB3 | PIK3R2 | psi-mi:“MI:0914”(association) | 0.700 |
| MRPS27 | MRPS14 | psi-mi:“MI:0914”(association) | 0.640 |
| YWHAH | BLTP3B | psi-mi:“MI:2364”(proximity) | 0.570 |
| NP | KPNA6 | psi-mi:“MI:0914”(association) | 0.550 |
| MRPS15 | MRPS14 | psi-mi:“MI:0914”(association) | 0.530 |
| TRMT10B | MRPS14 | psi-mi:“MI:0914”(association) | 0.530 |
| MRPS34 | ZZEF1 | psi-mi:“MI:0914”(association) | 0.530 |
| MRPS18C | MRPS14 | psi-mi:“MI:0914”(association) | 0.530 |
| MRPS15 | PRKACG | psi-mi:“MI:0914”(association) | 0.530 |
| MRPS27 | YBX1 | psi-mi:“MI:0914”(association) | 0.530 |
| MRPS34 | MRPS12 | psi-mi:“MI:0914”(association) | 0.530 |
| MRPS11 | MRPS14 | psi-mi:“MI:0914”(association) | 0.530 |
| CFAP20 | KPNA4 | psi-mi:“MI:0914”(association) | 0.510 |
| FUS | DDX3X | psi-mi:“MI:0914”(association) | 0.430 |
| FLT3 | MRPS28 | psi-mi:“MI:0915”(physical association) | 0.400 |
| NP | HNRNPDL | psi-mi:“MI:0914”(association) | 0.350 |
| NP | HNRNPAB | psi-mi:“MI:0914”(association) | 0.350 |
| NP | KPNA4 | psi-mi:“MI:0914”(association) | 0.350 |
| NP | KPNA6 | psi-mi:“MI:0914”(association) | 0.350 |
| NP | TRIM66 | psi-mi:“MI:0914”(association) | 0.350 |
| psi-mi:“MI:0914”(association) | 0.350 | ||
| DND1 | RPSA2 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (278): MRPS28 (Affinity Capture-MS), MRPS28 (Affinity Capture-MS), MRPS28 (Affinity Capture-MS), MRPS28 (Affinity Capture-MS), MRPS28 (Affinity Capture-MS), MRPS22 (Co-fractionation), MRPS27 (Co-fractionation), MRPS28 (Co-fractionation), MRPS28 (Co-fractionation), MRPS28 (Co-fractionation), MRPS28 (Affinity Capture-MS), MRPS28 (Affinity Capture-MS), MRPS28 (Affinity Capture-MS), MRPS28 (Affinity Capture-MS), MRPS28 (Affinity Capture-MS)
ESM2 similar proteins: A1L1P7, A6ZND9, A6ZSH0, B0BN56, B3LIY9, B3LPE4, B5VQB0, C5DKM2, D3ZYW7, F4I9Q5, O14320, O35658, O35796, O35943, O49196, P37841, P42797, P42844, P49727, P51132, P51133, P51135, P82928, Q01607, Q04907, Q05B87, Q07021, Q08230, Q09759, Q0IH40, Q16595, Q1JPN0, Q2KI49, Q3T0B6, Q5REH5, Q84WZ8, Q8HXX9, Q8N5N7, Q8VZE7, Q94JS0
Diamond homologs: P82928, Q9CY16, Q9Y2Q9
SIGNOR signaling
1 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| MRPS28 | “form complex” | “28S mitochondrial small ribosomal subunit” | binding |
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 130 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Mitochondrial translation initiation | 18 | 27.9× | 2e-19 |
| Mitochondrial translation elongation | 18 | 27.9× | 2e-19 |
| Mitochondrial ribosome-associated quality control | 18 | 27.0× | 3e-19 |
| Mitochondrial translation | 16 | 26.9× | 4e-17 |
| Mitochondrial translation termination | 18 | 24.1× | 2e-18 |
| Translation | 18 | 13.6× | 4e-14 |
| mRNA Polyadenylation | 10 | 10.7× | 2e-06 |
| Processing of Capped Intron-Containing Pre-mRNA | 8 | 8.0× | 3e-04 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| mitochondrial translation | 17 | 26.9× | 3e-17 |
| RNA processing | 6 | 11.9× | 2e-03 |
| regulation of alternative mRNA splicing, via spliceosome | 5 | 11.1× | 6e-03 |
| translation | 10 | 9.3× | 4e-05 |
| mRNA processing | 10 | 7.2× | 3e-04 |
| RNA splicing | 8 | 6.4× | 3e-03 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
90 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 0 |
| Uncertain significance | 54 |
| Likely benign | 16 |
| Benign | 4 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 973977 | NM_014018.3(MRPS28):c.356A>G (p.Lys119Arg) | Pathogenic |
SpliceAI
2730 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 12:27710951:CCTGC:C | donor_gain | 1.0000 |
| 12:27710954:GC:G | donor_gain | 1.0000 |
| 12:27710956:G:GG | donor_gain | 1.0000 |
| 12:27714773:C:CA | acceptor_gain | 1.0000 |
| 12:27714777:C:G | acceptor_gain | 1.0000 |
| 12:27716289:A:AG | acceptor_gain | 1.0000 |
| 12:27716289:AG:A | acceptor_gain | 1.0000 |
| 12:27716290:G:GA | acceptor_gain | 1.0000 |
| 12:27716290:GG:G | acceptor_gain | 1.0000 |
| 12:27716290:GGC:G | acceptor_gain | 1.0000 |
| 12:27716290:GGCA:G | acceptor_gain | 1.0000 |
| 12:27716290:GGCAC:G | acceptor_gain | 1.0000 |
| 12:27716457:AGG:A | donor_loss | 1.0000 |
| 12:27716458:GGT:G | donor_loss | 1.0000 |
| 12:27716459:G:GC | donor_loss | 1.0000 |
| 12:27716459:G:GG | donor_gain | 1.0000 |
| 12:27716460:T:G | donor_loss | 1.0000 |
| 12:27719805:A:AG | acceptor_gain | 1.0000 |
| 12:27719806:A:G | acceptor_gain | 1.0000 |
| 12:27724039:A:AG | acceptor_gain | 1.0000 |
| 12:27724042:CTCA:C | acceptor_loss | 1.0000 |
| 12:27724043:TCAG:T | acceptor_loss | 1.0000 |
| 12:27724045:A:AG | acceptor_gain | 1.0000 |
| 12:27724045:AG:A | acceptor_loss | 1.0000 |
| 12:27724046:G:GA | acceptor_gain | 1.0000 |
| 12:27724046:GA:G | acceptor_gain | 1.0000 |
| 12:27724046:GAT:G | acceptor_gain | 1.0000 |
| 12:27724046:GATT:G | acceptor_gain | 1.0000 |
| 12:27724046:GATTT:G | acceptor_gain | 1.0000 |
| 12:27724173:T:TA | donor_gain | 1.0000 |
AlphaMissense
1207 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 8:80003034:A:C | F120L | 0.994 |
| 8:80003034:A:T | F120L | 0.994 |
| 8:80003036:A:G | F120L | 0.994 |
| 8:79919085:G:C | F153L | 0.987 |
| 8:79919085:G:T | F153L | 0.987 |
| 8:79919087:A:G | F153L | 0.987 |
| 8:80003046:A:C | F116L | 0.981 |
| 8:80003046:A:T | F116L | 0.981 |
| 8:80003048:A:G | F116L | 0.981 |
| 8:80003053:A:T | I114K | 0.981 |
| 8:79919119:A:G | L142S | 0.980 |
| 8:80003028:A:C | C122W | 0.978 |
| 8:80003154:A:C | F80L | 0.976 |
| 8:80003154:A:T | F80L | 0.976 |
| 8:80003156:A:G | F80L | 0.976 |
| 8:79919051:C:G | A165P | 0.972 |
| 8:80003035:A:G | F120S | 0.970 |
| 8:80003037:C:A | K119N | 0.968 |
| 8:80003037:C:G | K119N | 0.968 |
| 8:80003083:A:G | I104T | 0.968 |
| 8:79919125:A:T | V140D | 0.967 |
| 8:80003059:A:G | L112P | 0.967 |
| 8:80003089:C:T | G102E | 0.966 |
| 8:80003053:A:C | I114R | 0.965 |
| 8:80003035:A:C | F120C | 0.964 |
| 8:80003030:A:G | C122R | 0.962 |
| 8:79919052:C:A | E164D | 0.960 |
| 8:79919052:C:G | E164D | 0.960 |
| 8:80003029:C:T | C122Y | 0.960 |
| 8:79919044:G:T | A167E | 0.958 |
dbSNP variants (sampled 300 via entrez): RS1000016614 (8:79921506 A>G), RS1000030716 (8:80003998 C>A), RS1000047104 (8:80006569 T>C), RS1000096182 (8:79919861 A>G), RS1000113992 (8:79977157 T>A), RS1000153799 (8:79931458 C>A), RS1000193242 (8:80000854 C>T), RS1000199547 (8:79979630 C>A,T), RS1000238107 (8:80017018 G>C), RS1000254669 (8:79950317 C>T), RS1000255740 (8:79957480 G>A,C,T), RS1000269377 (8:79935206 A>G), RS1000308625 (8:79924290 G>T), RS1000311560 (8:79957148 C>A,T), RS1000340643 (8:79934802 G>A)
Disease associations
OMIM: gene MIM:611990 | disease phenotypes: MIM:618958
GenCC curated gene-disease
| Disease | Classification | Inheritance |
|---|---|---|
| combined oxidative phosphorylation deficiency 47 | Limited | Autosomal recessive |
ClinGen Gene-Disease Validity (1)
Expert-panel classifications — Definitive > Strong > Moderate > Limited > Disputed > Refuted.
| Disease | Classification | Inheritance |
|---|---|---|
| mitochondrial disease | Limited | AR |
Mondo (1): combined oxidative phosphorylation deficiency 47 (MONDO:0033537)
Orphanet (0):
HPO phenotypes
25 total (25 of 25 shown, HPO-id order):
| HPO | Term |
|---|---|
| HP:0000007 | Autosomal recessive inheritance |
| HP:0000028 | Cryptorchidism |
| HP:0000252 | Microcephaly |
| HP:0000311 | Round face |
| HP:0000343 | Long philtrum |
| HP:0000358 | Posteriorly rotated ears |
| HP:0000369 | Low-set ears |
| HP:0000407 | Sensorineural hearing impairment |
| HP:0000470 | Short neck |
| HP:0000508 | Ptosis |
| HP:0000518 | Cataract |
| HP:0000926 | Platyspondyly |
| HP:0001290 | Generalized hypotonia |
| HP:0001508 | Failure to thrive |
| HP:0001511 | Intrauterine growth retardation |
| HP:0001770 | Toe syndactyly |
| HP:0001942 | Metabolic acidosis |
| HP:0001943 | Hypoglycemia |
| HP:0001944 | Dehydration |
| HP:0002015 | Dysphagia |
| HP:0002151 | Increased circulating lactate concentration |
| HP:0002240 | Hepatomegaly |
| HP:0002910 | Elevated circulating hepatic transaminase concentration |
| HP:0004279 | Short palm |
| HP:0010248 | Cone-shaped epiphyses of the distal phalanges of the hand |
GWAS associations
5 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST006979_464 | Heel bone mineral density | 3.000000e-20 |
| GCST007515_36 | Type 2 diabetes | 1.000000e-11 |
| GCST007516_16 | Type 2 diabetes (adjusted for BMI) | 2.000000e-08 |
| GCST009798_21 | Asthma | 6.000000e-22 |
| GCST010796_4129 | Electrocardiogram morphology (amplitude at temporal datapoints) | 2.000000e-09 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0009270 | heel bone mineral density |
| EFO:0004327 | electrocardiography |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: yes
ChEMBL targets (1): CHEMBL6067452 (SINGLE PROTEIN)
PharmGKB: 1 entry (VIP=true, CPIC=false)
ChEMBL bioactivities
2 potent at pChembl≥5 of 2 total, top 2 by pChembl (potency: 10 = 0.1 nM, 6 = 1 µM).
| pChembl | Type | Value | Unit | Molecule |
|---|---|---|---|---|
| 6.57 | Kd | 271.2 | nM | CHEMBL3752910 |
| 6.57 | ED50 | 271.2 | nM | CHEMBL3752910 |
PubChem BioAssay actives
1 with measured affinity, of 2 total; 1 most potent distinct compounds. Largely complementary to BindingDB; screening values are coarse (µM, 4 dp), so sub-nM hits tie at the floor.
| Compound | Assay | Type | Value | Unit |
|---|---|---|---|---|
| 4-methyl-3-[(1-methyl-6-pyridin-3-ylpyrazolo[3,4-d]pyrimidin-4-yl)amino]-N-[3-(trifluoromethyl)phenyl]benzamide | 2149889: Binding affinity to human MRPS28 incubated for 45 mins by Kinobead based pull down assay | kd | 0.2712 | uM |
CTD chemical–gene interactions
35 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | decreases expression, increases expression | 3 |
| aristolochic acid I | decreases expression | 1 |
| bisphenol F | affects cotreatment, increases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| bisphenol A | decreases expression | 1 |
| beta-lapachone | decreases expression | 1 |
| arsenite | affects binding, increases reaction | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | decreases expression | 1 |
| K 7174 | decreases expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, decreases expression | 1 |
| erucylphospho-N,N,N-trimethylpropylammonium | decreases expression | 1 |
| LDN 193189 | affects cotreatment, decreases expression | 1 |
| MT19c compound | increases expression | 1 |
| Decitabine | decreases expression | 1 |
| Sunitinib | decreases expression | 1 |
| Acetaminophen | decreases expression | 1 |
| Air Pollutants | decreases expression, increases abundance | 1 |
| Atrazine | decreases expression | 1 |
| Benzo(a)pyrene | decreases expression | 1 |
| Cannabidiol | increases expression | 1 |
| Dichlorodiphenyl Dichloroethylene | increases expression | 1 |
| Dexamethasone | affects cotreatment, increases expression | 1 |
| Dust | decreases expression | 1 |
| Ethyl Methanesulfonate | decreases expression | 1 |
| Indomethacin | affects cotreatment, increases expression | 1 |
| Progesterone | decreases expression | 1 |
| Ribonucleotides | affects binding | 1 |
| Sarin | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Tunicamycin | decreases expression | 1 |
ChEMBL screening assays
1 unique, capped per target: 1 binding
Representative assays (with source publication via chembl_document):
| Assay ID | Type | Description | Source paper |
|---|---|---|---|
| CHEMBL5652931 | Binding | Binding affinity to human MRPS28 incubated for 45 mins by Kinobead based pull down assay | NVP-BHG712: Effects of Regioisomers on the Affinity and Selectivity toward the EPHrin Family. — ChemMedChem |
Cellosaurus cell lines
1 cell lines: 1 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_B3BB | Abcam HEK293T MRPS28 KO | Transformed cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Associated diseases: combined oxidative phosphorylation deficiency 47, mitochondrial disease
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): combined oxidative phosphorylation deficiency 47